Tower Research Capital LLC (TRC) - TFF PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TFF PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,858
-12.7%
13,879
+17.2%
0.00%
Q2 2023$5,565
+55550.0%
11,841
-18.6%
0.00%
Q1 2023$10
+100.0%
14,555
+208.5%
0.00%
Q4 2022$5
-100.0%
4,718
+6.8%
0.00%
Q3 2022$18,000
-33.3%
4,418
-6.9%
0.00%
-100.0%
Q2 2022$27,000
-38.6%
4,746
-32.3%
0.00%
Q1 2022$44,000
+300.0%
7,014
+437.1%
0.00%
Q4 2021$11,000
-78.0%
1,306
-75.2%
0.00%
-100.0%
Q2 2021$50,000
+316.7%
5,276
+484.3%
0.00%
Q1 2021$12,000
+200.0%
903
+201.0%
0.00%
Q4 2020$4,0003000.00%
Other shareholders
TFF PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,565,682$21,246,0007.82%
APIS CAPITAL ADVISORS, LLC 182,500$2,477,0002.25%
Altium Capital Management LP 269,691$3,660,0001.02%
Mesirow Financial Investment Management, Inc. 27,216$369,0001.00%
PRECEPT MANAGEMENT LLC 107,300$1,456,0000.99%
Gagnon Advisors, LLC 176,471$2,395,0000.99%
GAGNON SECURITIES LLC 377,976$5,129,0000.78%
P.A.W. CAPITAL CORP 63,695$864,0000.76%
Diametric Capital, LP 32,868$446,0000.34%
DRW Securities, LLC 513,400$6,967,0000.28%
View complete list of TFF PHARMACEUTICALS INC shareholders